Index
Module 7 • Infectious Diseases
Infectious Diseases II
95%
Core Content
Infectious Diseases II
Gabrielle Gibson ~2 min read Module 7 of 20
72
/ 76

Infectious Diseases II

Antifungal Therapy

Limper AH, Knox KS, Sarosi GA, et al. An official

American Thoracic Society statement: treatment of

fungal infections in adult pulmonary and critical care

patients. Am J Respir Crit Care Med. 2011;183(1):96-

128. https://doi.org/10.1164/rccm.2008-740st

Miceli MH, Kauffman CA. Isavuconazole: a new broad-

spectrum triazole antifungal agent. Clin Infect Dis.

2015;61(10):1558-1565. https://doi.org/10.1093/cid/civ571

Pappas PG, Kauffman CA, Andes DR, et al. Clinical

practice guideline for the management of candidia-

sis: 2016 update by the Infectious Diseases Society of

America. Clin Infect Dis. 2016;62(4):e1-e50. https://doi.

org/10.1093/cid/civ933

Thompson GR 3rd, Soriano A, Cornely OA, et al.

Rezafungin versus caspofungin for treatment of

candidaemia and invasive candidiasis (ReSTORE): a

multicentre, double-blind, double-dummy, randomised

phase 3 trial. Lancet. 2023;401(10370):49-59. https://doi.

org/10.1016/s0140-6736(22)02324-8

Timsit JF, Azoulay E, Schwebel C, et al. Empirical mica-

fungin treatment and survival without invasive fungal

infection in adults with ICU-acquired sepsis, Candida

colonization, and multiple organ failure: the EMPIRICUS

randomized clinical trial. JAMA. 2016;316(15):1555-

1564. https://doi.org/10.1001/jama.2016.14655

Social Determinants of Health and Infectious

Diseases

Abrams EM, Szefler SJ. COVID-19 and the impact

of social determinants of health. Lancet Respir

Med.

2020;8(7):659-661.

https://doi.org/10.1016/

s2213-2600(20)30234-4

Centers for Disease Control and Prevention. Social deter-

minants of health: know what affects health. Centers for

Disease Control and Prevention; 2024. www.cdc.gov/

socialdeterminants

National Center for HIV/AIDS, Viral Hepatitis, STD,

and TB Prevention (NCHHSTP). Establishing a holis-

tic framework to reduce inequities in HIV, viral

hepatitis, STDs, and tuberculosis in the United States.

An NCHHSTP white paper on social determinants of

health. 2010. www.cdc.gov/socialdeterminants/docs/sdh-

white-paper-2010.pdf

Osae SP, Chastain SB, Young HN. Pharmacist role

in addressing health disparities. Part 2. Strategies to

move toward health equity. J Am Coll Clin Pharm

2022;5(5):541-550. https://doi.org/10.1002/jac5.1594

Singu S, Acharya A, Challagundla K, Byrareddy SN.

Impact of social determinants of health on the emerg-

ing COVID-19 pandemic in the United States. Front

Public Health. 2020;8:406. https://doi.org/10.3389/

fpubh.2020.00406

HD Video Explanation โ€” Synchronized with PDF
Starts at: minute 71 Open on YouTube